Pelvis & Reproductive Organs

What imaging can show of the prostate, uterus and ovaries — and the screening tests it does not replace.

Last updated October 2026 · New Dawn Health editorial team

The organs here differ by sex, but the reading does not. Most of what imaging finds in the pelvis is benign, and the job is to write it down and measure it again later.

A technologist reaching across the MRI table to strap a flexible body coil across a patient's hips.
Most findings here are a fibroid or a cyst, measured again later.

What gets checked, and with what

A survey MRI can reach all three; ultrasound looks closer at a finding.
Organ What imaging looks for The test that does it
Prostate Enlargement, nodules and lesions that could point to cancer The pelvic sequences of a full-body MRI, when the protocol includes them; a PSA test on a blood panel
Uterus Fibroids, and structural change to the wall and cavity The same MRI sequences, with ultrasound to look closer at a finding
Ovaries Cysts and masses The same MRI sequences; ultrasound is the usual test for looking closely at a cyst

Prostate

  • A survey MRI is not a dedicated prostate MRI. The MRI used after a raised PSA is a multiparametric prostate MRI, a longer and more focused protocol.
  • PSA is imperfect: it can be raised for benign reasons, such as an enlarged prostate or an infection. It is weighed with your age and history — not as a standalone yes-or-no.
  • Worth reading first: the blood panel page carries the USPSTF position on PSA in full, including what it says differently for men aged 55–69 and for men aged 70 and over.

Uterus

  • Most common finding: a fibroid — a benign muscular growth, very frequent, and usually monitored rather than treated.
  • Imaging can't: confirm on its own that tissue is benign. That judgment combines the images with your symptoms and, when needed, a dedicated gynecology exam.

Ovaries

  • Most common finding: a cyst. Most are benign and are simply monitored — a repeat scan after an interval confirms it is stable or resolving.
  • Imaging can't: always separate a simple cyst from one that needs closer attention. Many findings are graded and followed, but a suspicious mass or sudden pelvic pain needs prompt specialist assessment.
  • CA-125 is not a screening test: it can be raised by endometriosis (lining-like tissue growing outside the uterus), fibroids, a menstrual period or pregnancy. Its established use is monitoring a known finding; women at high risk need specialist advice.

What this region's screening does not cover

What the pelvic sequences give you
  • All three organs on a survey MRI, when its protocol includes the pelvis
  • A PSA result to read alongside the prostate image, for men who have chosen PSA testing
  • A baseline, for findings whose entire meaning is "has this changed?"
What they do not
  • Incidental fibroids and cysts are the expected result here rather than a failed scan. Most are watched, not treated.
  • Cervical screening. A Pap or HPV test at a gynecology exam does that; a pelvic MRI does not.
  • Breast screening — see the chest page.
  • A prostate cancer workup. That needs a dedicated prostate MRI and a urologist.
  • Whether tissue is benign. Imaging describes size, shape and borders; only sampling settles the question.

Sources & further reading

  1. [1] Taiwan national cancer screening programs — Pap 25–29 every 3 years, yearly from 30 (at least every 3 years recommended); HPV test once at 35, 45 and 65 — Health Promotion Administration, Ministry of Health and Welfare (Taiwan)
  2. [2] Prostate Cancer: Screening (2018) — individual decision at 55–69; against from 70 — US Preventive Services Task Force
  3. [3] Ovarian Cancer: Screening (2018, "D" — against screening women without symptoms) — US Preventive Services Task Force
  4. [4] Prostate MRI — patient guide (multiparametric MRI) — RadiologyInfo.org (RSNA/ACR)
  5. [5] CA-125 blood test — benign causes of a raised level — MedlinePlus (NIH)
  6. [6] Body MRI — patient guide — RadiologyInfo.org (RSNA/ACR)
  7. [7] MRI safety: implants, devices, pregnancy and gadolinium contrast — RadiologyInfo.org (RSNA/ACR)

Pelvis & Reproductive Organs — Frequently Asked Questions

Does a pelvic MRI screen for prostate cancer?

Not on its own. A survey MRI can show the prostate, but the MRI used after a raised PSA is a dedicated multiparametric prostate MRI, a different protocol. PSA can also rise for benign reasons. A concerning finding goes to a urologist rather than being treated from the scan.

Are ovarian cysts found on screening dangerous?

Usually not. Most ovarian cysts are benign and are monitored with a repeat scan to confirm they are stable or resolving. Imaging cannot always separate a simple cyst from one needing closer attention. Many findings are followed with repeat imaging, but a suspicious mass or sudden pelvic pain needs prompt specialist assessment.

Does this screening replace a Pap smear?

No. A pelvic MRI shows the uterus and ovaries, but it does not test the cervix for the cell changes a Pap or HPV test detects. In Taiwan, the Health Promotion Administration funds a Pap test every 3 years at 25–29 and yearly from 30. Cervical screening is a separate gynecologic exam.

Screen smart. Travel once. Know where you stand.

Compare screening packages, see exactly what each one includes, or talk to a coordinator about fitting Pelvis & Reproductive Organs screening into your visit to Taiwan.